摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(1-(2-(4-isopropylpiperazin-1-yl)ethoxy)dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one

中文名称
——
中文别名
——
英文名称
8-(1-(2-(4-isopropylpiperazin-1-yl)ethoxy)dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one
英文别名
2-Morpholin-4-yl-8-[1-[2-(4-propan-2-ylpiperazin-1-yl)ethoxy]dibenzothiophen-4-yl]chromen-4-one
8-(1-(2-(4-isopropylpiperazin-1-yl)ethoxy)dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one化学式
CAS
——
化学式
C34H37N3O4S
mdl
——
分子量
583.751
InChiKey
KERUUMIVCIEOOT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    42
  • 可旋转键数:
    7
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    82.7
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 1-Substituted (Dibenzo[<i>b,d</i>]thiophen-4-yl)-2-morpholino-4<i>H</i>-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity
    作者:Céline Cano、Kappusamy Saravanan、Chris Bailey、Julia Bardos、Nicola J. Curtin、Mark Frigerio、Bernard T. Golding、Ian R. Hardcastle、Marc G. Hummersone、Keith A. Menear、David R. Newell、Caroline J. Richardson、K. Shea、Graeme C. M. Smith、Pia Thommes、Attilla Ting、Roger J. Griffin
    DOI:10.1021/jm400915j
    日期:2013.8.22
    Analogues of (dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-one (NU7441), a potent inhibitor of DNA-dependent protein kinase (DNA-PK; IC50 = 42 +/- 2 nM), have been synthesized in which water-solubilizing groups [NHCO(CH2)(n)(NRR2)-R-1, where n = 1 or 2 and the moiety (RRN)-R-1-N-2 was derived from a library of primary and secondary amines, e.g., morpholine] were placed at the 1-position. Several of the newly synthesized compounds exhibited high potency against DNA-PK and potentiated the cytotoxicity of ionizing radiation (IR) in vitro 10-fold or more (e.g., 2-(4-ethyl-piperazin-1-yl)-N-(4-(2-morpholino-4-oxo-4H-chromen-8-yl)-dibenzo[b,d]thio-phen-1-yl)acetamide, 39; DNA-PK IC50 = 5.0 +/- 1 nM, IR dose modification ratio = 13). Furthermore, 39 was shown to potentiate not only IR in vitro but also DNA-inducing cytotoxic anticancer agents, both in vitro and in vivo. Counter-screening against other members of the phosphatidylinositol 3-kinase (PI-3K) related kinase (PIKK) family unexpectedly revealed that some of the compounds were potent mixed DNA-PK and PI-3K inhibitors.
查看更多

同类化合物